CORE LABORATORIES INC (CLB) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CLB - US21867A1051 - Common Stock
18.97 USD
+0.09 (+0.48%)
18.97 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to CLB. CLB was compared to 62 industry peers in the Energy Equipment & Services industry. While CLB has a great health rating, its profitability is only average at the moment. CLB has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
CLB had positive earnings in the past year.
CLB had a positive operating cash flow in the past year.
CLB had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CLB had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.43%, CLB is in the better half of the industry, outperforming 70.97% of the companies in the same industry.
CLB has a Return On Equity of 11.84%. This is in the better half of the industry: CLB outperforms 75.81% of its industry peers.
The Return On Invested Capital of CLB (9.29%) is better than 74.19% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLB is below the industry average of 12.77%.
The 3 year average ROIC (8.80%) for CLB is below the current ROIC(9.29%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROIC | 9.29% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
1.3 Margins
CLB has a Profit Margin of 6.21%. This is in the better half of the industry: CLB outperforms 62.90% of its industry peers.
CLB's Profit Margin has declined in the last couple of years.
CLB's Operating Margin of 11.16% is fine compared to the rest of the industry. CLB outperforms 61.29% of its industry peers.
In the last couple of years the Operating Margin of CLB has declined.
With a Gross Margin value of 19.95%, CLB is not doing good in the industry: 69.35% of the companies in the same industry are doing better.
CLB's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% |
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
2. Health
2.1 Basic Checks
CLB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CLB has about the same amount of shares outstanding.
CLB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CLB has been reduced compared to a year ago.
2.2 Solvency
CLB has an Altman-Z score of 3.53. This indicates that CLB is financially healthy and has little risk of bankruptcy at the moment.
CLB has a Altman-Z score of 3.53. This is amongst the best in the industry. CLB outperforms 82.26% of its industry peers.
The Debt to FCF ratio of CLB is 3.32, which is a good value as it means it would take CLB, 3.32 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CLB (3.32) is better than 64.52% of its industry peers.
CLB has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.42, CLB is in line with its industry, outperforming 56.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Altman-Z | 3.53 |
ROIC/WACC1.07
WACC8.7%
2.3 Liquidity
CLB has a Current Ratio of 2.37. This indicates that CLB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.37, CLB is in the better half of the industry, outperforming 69.35% of the companies in the same industry.
A Quick Ratio of 1.76 indicates that CLB should not have too much problems paying its short term obligations.
CLB's Quick ratio of 1.76 is fine compared to the rest of the industry. CLB outperforms 67.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 |
3. Growth
3.1 Past
CLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.41%.
The earnings per share for CLB have been decreasing by -13.14% on average. This is quite bad
CLB shows a decrease in Revenue. In the last year, the revenue decreased by -1.02%.
Measured over the past years, CLB shows a decrease in Revenue. The Revenue has been decreasing by -4.75% on average per year.
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
3.2 Future
CLB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.78% yearly.
The Revenue is expected to grow by 3.47% on average over the next years.
EPS Next Y-15.64%
EPS Next 2Y-7.43%
EPS Next 3Y2.56%
EPS Next 5Y12.78%
Revenue Next Year-1.75%
Revenue Next 2Y-1.26%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
CLB is valuated rather expensively with a Price/Earnings ratio of 24.64.
Compared to the rest of the industry, the Price/Earnings ratio of CLB is on the same level as its industry peers.
CLB's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.19.
A Price/Forward Earnings ratio of 25.15 indicates a quite expensive valuation of CLB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLB is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.92, CLB is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.64 | ||
| Fwd PE | 25.15 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CLB is valued more expensive than 80.65% of the companies in the same industry.
CLB's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.69 | ||
| EV/EBITDA | 13.42 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.43%
EPS Next 3Y2.56%
5. Dividend
5.1 Amount
With a yearly dividend of 0.21%, CLB is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.21, CLB has a dividend in line with its industry peers.
With a Dividend Yield of 0.21, CLB pays less dividend than the S&P500 average, which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.21% |
5.2 History
The dividend of CLB decreases each year by -55.13%.
CLB has paid a dividend for at least 10 years, which is a reliable track record.
CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-55.13%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
CLB pays out 5.83% of its income as dividend. This is a sustainable payout ratio.
DP5.83%
EPS Next 2Y-7.43%
EPS Next 3Y2.56%
18.97
+0.09 (+0.48%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)
Earnings (Next)
Inst Owners113.63%
Inst Owner Change1.41%
Ins Owners1.02%
Ins Owner Change7.46%
Market Cap883.24M
Revenue(TTM)517.50M
Net Income(TTM)32.12M
Analysts48
Price Target15.64 (-17.55%)
Short Float %9.28%
Short Ratio8.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.21% |
Yearly Dividend0.04
Dividend Growth(5Y)-55.13%
DP5.83%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.26%
Min EPS beat(2)-0.33%
Max EPS beat(2)12.86%
EPS beat(4)1
Avg EPS beat(4)1.9%
Min EPS beat(4)-4.67%
Max EPS beat(4)12.86%
EPS beat(8)4
Avg EPS beat(8)4.82%
EPS beat(12)7
Avg EPS beat(12)5.16%
EPS beat(16)8
Avg EPS beat(16)3.39%
Revenue beat(2)2
Avg Revenue beat(2)0.73%
Min Revenue beat(2)0.02%
Max Revenue beat(2)1.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)1.44%
Revenue beat(8)3
Avg Revenue beat(8)-0.5%
Revenue beat(12)4
Avg Revenue beat(12)-1.2%
Revenue beat(16)5
Avg Revenue beat(16)-1.06%
PT rev (1m)0%
PT rev (3m)11.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.66%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.98%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)1.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.64 | ||
| Fwd PE | 25.15 | ||
| P/S | 1.71 | ||
| P/FCF | 25.69 | ||
| P/OCF | 17.77 | ||
| P/B | 3.26 | ||
| P/tB | 5.35 | ||
| EV/EBITDA | 13.42 |
EPS(TTM)0.77
EY4.06%
EPS(NY)0.75
Fwd EY3.98%
FCF(TTM)0.74
FCFY3.89%
OCF(TTM)1.07
OCFY5.63%
SpS11.11
BVpS5.83
TBVpS3.55
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROCE | 11.66% | ||
| ROIC | 9.29% | ||
| ROICexc | 9.8% | ||
| ROICexgc | 12.66% | ||
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% | ||
| FCFM | 6.64% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
ROICexc(3y)9.11%
ROICexc(5y)8.99%
ROICexgc(3y)11.75%
ROICexgc(5y)11.63%
ROCE(3y)11.03%
ROCE(5y)10.9%
ROICexgc growth 3Y11.32%
ROICexgc growth 5Y-6.37%
ROICexc growth 3Y11.52%
ROICexc growth 5Y-2.86%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
F-Score7
Asset Turnover0.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Debt/EBITDA | 1.58 | ||
| Cap/Depr | 104.6% | ||
| Cap/Sales | 2.96% | ||
| Interest Coverage | 6.66 | ||
| Cash Conversion | 68.62% | ||
| Profit Quality | 107.03% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 | ||
| Altman-Z | 3.53 |
F-Score7
WACC8.7%
ROIC/WACC1.07
Cap/Depr(3y)71.15%
Cap/Depr(5y)68.67%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.39%
Profit Quality(3y)84.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
EPS Next Y-15.64%
EPS Next 2Y-7.43%
EPS Next 3Y2.56%
EPS Next 5Y12.78%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
Revenue Next Year-1.75%
Revenue Next 2Y-1.26%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
EBIT growth 1Y-6.83%
EBIT growth 3Y11.62%
EBIT growth 5Y-8.87%
EBIT Next Year11.19%
EBIT Next 3Y8.03%
EBIT Next 5Y17.46%
FCF growth 1Y286.32%
FCF growth 3Y23.36%
FCF growth 5Y-8.39%
OCF growth 1Y165.78%
OCF growth 3Y15.5%
OCF growth 5Y-8.83%
CORE LABORATORIES INC / CLB FAQ
Can you provide the ChartMill fundamental rating for CORE LABORATORIES INC?
ChartMill assigns a fundamental rating of 5 / 10 to CLB.
Can you provide the valuation status for CORE LABORATORIES INC?
ChartMill assigns a valuation rating of 2 / 10 to CORE LABORATORIES INC (CLB). This can be considered as Overvalued.
Can you provide the profitability details for CORE LABORATORIES INC?
CORE LABORATORIES INC (CLB) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for CLB stock?
The Price/Earnings (PE) ratio for CORE LABORATORIES INC (CLB) is 24.64 and the Price/Book (PB) ratio is 3.26.
What is the expected EPS growth for CORE LABORATORIES INC (CLB) stock?
The Earnings per Share (EPS) of CORE LABORATORIES INC (CLB) is expected to decline by -15.64% in the next year.